Booster Shot for Brii Biosciences with First Covid Drug Launch
Brii Biosciences announced the commercial launch of its injectable Covid antibody treatment, which will be covered by government medical insurance in many parts of the country Key Takeaways: The antibody…
Recent Articles
RELATED ARTICLES
-
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK 688150.SHG
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
HBM gets health boost from drug licensing deals
2142.HK
-
Missing the Covid boat, Junshi stumbles back to old business
1877.HK 688180.SHG
-
FAST NEWS: Brii Bioscience shares rise on favorable hepatitis B data
2137.HK
-
Junshi hopes new scientist CEO can cure its woes
1877.HK 688180.SHG
Discover hidden China stock gems in our weekly newsletter